AKT1 and urinary bladder cancer: In conclusion, LINC00641 can competitively bind to miR-197-3p through the ceRNA mechanism to increase the expression of KLF10, further inhibit the activation of PTEN/PI3K/AKT pathway, and inhibit the proliferation, migration and invasion of bladder cancer cells.